nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CA6—submandibular gland—pharynx cancer	0.0941	0.134	CbGeAlD
Imatinib—CA6—saliva—pharynx cancer	0.0339	0.0483	CbGeAlD
Imatinib—CA6—ear—pharynx cancer	0.031	0.0442	CbGeAlD
Imatinib—CA3—ear—pharynx cancer	0.0293	0.0418	CbGeAlD
Imatinib—ORM1—saliva—pharynx cancer	0.018	0.0257	CbGeAlD
Imatinib—ABCA3—parotid gland—pharynx cancer	0.0155	0.0221	CbGeAlD
Imatinib—ABCA3—saliva-secreting gland—pharynx cancer	0.0149	0.0212	CbGeAlD
Imatinib—DDR1—parotid gland—pharynx cancer	0.0143	0.0204	CbGeAlD
Imatinib—DDR1—saliva-secreting gland—pharynx cancer	0.0137	0.0196	CbGeAlD
Imatinib—CA6—mouth—pharynx cancer	0.0128	0.0183	CbGeAlD
Imatinib—CA3—mouth—pharynx cancer	0.0121	0.0173	CbGeAlD
Imatinib—DDR1—trachea—pharynx cancer	0.0106	0.0151	CbGeAlD
Imatinib—ABCA3—spinal cord—pharynx cancer	0.00906	0.0129	CbGeAlD
Imatinib—CA6—parotid gland—pharynx cancer	0.00892	0.0127	CbGeAlD
Imatinib—PIP4K2C—parotid gland—pharynx cancer	0.00885	0.0126	CbGeAlD
Imatinib—CA6—saliva-secreting gland—pharynx cancer	0.00855	0.0122	CbGeAlD
Imatinib—PIP4K2C—saliva-secreting gland—pharynx cancer	0.00848	0.0121	CbGeAlD
Imatinib—CA3—parotid gland—pharynx cancer	0.00845	0.012	CbGeAlD
Imatinib—DDR1—spinal cord—pharynx cancer	0.00837	0.0119	CbGeAlD
Imatinib—ABCA3—head—pharynx cancer	0.00806	0.0115	CbGeAlD
Imatinib—KIT—mouth—pharynx cancer	0.00744	0.0106	CbGeAlD
Imatinib—CA7—trachea—pharynx cancer	0.00681	0.0097	CbGeAlD
Imatinib—PIP4K2C—trachea—pharynx cancer	0.00654	0.00932	CbGeAlD
Imatinib—NQO2—parotid gland—pharynx cancer	0.0065	0.00926	CbGeAlD
Imatinib—KIT—neck—pharynx cancer	0.00636	0.00907	CbGeAlD
Imatinib—NQO2—saliva-secreting gland—pharynx cancer	0.00623	0.00887	CbGeAlD
Imatinib—PDGFRB—neck—pharynx cancer	0.00622	0.00886	CbGeAlD
Imatinib—NQO2—brainstem—pharynx cancer	0.0061	0.00869	CbGeAlD
Imatinib—LCK—trachea—pharynx cancer	0.0058	0.00827	CbGeAlD
Imatinib—ABCA3—lymph node—pharynx cancer	0.00564	0.00804	CbGeAlD
Imatinib—DDR1—lymph node—pharynx cancer	0.00521	0.00742	CbGeAlD
Imatinib—KIT—parotid gland—pharynx cancer	0.00518	0.00739	CbGeAlD
Imatinib—PIP4K2C—spinal cord—pharynx cancer	0.00516	0.00736	CbGeAlD
Imatinib—PDGFRB—parotid gland—pharynx cancer	0.00506	0.00722	CbGeAlD
Imatinib—KIT—saliva-secreting gland—pharynx cancer	0.00496	0.00708	CbGeAlD
Imatinib—SLC47A1—brainstem—pharynx cancer	0.00489	0.00697	CbGeAlD
Imatinib—KIT—brainstem—pharynx cancer	0.00486	0.00693	CbGeAlD
Imatinib—PDGFRB—saliva-secreting gland—pharynx cancer	0.00485	0.00691	CbGeAlD
Imatinib—NQO2—trachea—pharynx cancer	0.0048	0.00684	CbGeAlD
Imatinib—PDGFRA—trachea—pharynx cancer	0.00479	0.00683	CbGeAlD
Imatinib—CA6—head—pharynx cancer	0.00463	0.00659	CbGeAlD
Imatinib—PIP4K2C—head—pharynx cancer	0.00459	0.00654	CbGeAlD
Imatinib—ABL1—parotid gland—pharynx cancer	0.00451	0.00643	CbGeAlD
Imatinib—CA14—spinal cord—pharynx cancer	0.00448	0.00638	CbGeAlD
Imatinib—CA12—trachea—pharynx cancer	0.00442	0.0063	CbGeAlD
Imatinib—CA2—mouth—pharynx cancer	0.00441	0.00629	CbGeAlD
Imatinib—CA3—head—pharynx cancer	0.00438	0.00625	CbGeAlD
Imatinib—KIT—epithelium—pharynx cancer	0.00433	0.00617	CbGeAlD
Imatinib—ABL1—saliva-secreting gland—pharynx cancer	0.00432	0.00616	CbGeAlD
Imatinib—ABL1—brainstem—pharynx cancer	0.00423	0.00603	CbGeAlD
Imatinib—PDGFRB—epithelium—pharynx cancer	0.00423	0.00603	CbGeAlD
Imatinib—CSF1R—trachea—pharynx cancer	0.00422	0.00601	CbGeAlD
Imatinib—PDGFRA—lymphoid tissue—pharynx cancer	0.00417	0.00595	CbGeAlD
Imatinib—KIT—trachea—pharynx cancer	0.00383	0.00546	CbGeAlD
Imatinib—NQO2—spinal cord—pharynx cancer	0.00379	0.00541	CbGeAlD
Imatinib—PDGFRA—spinal cord—pharynx cancer	0.00378	0.00539	CbGeAlD
Imatinib—CA2—neck—pharynx cancer	0.00377	0.00538	CbGeAlD
Imatinib—PDGFRB—trachea—pharynx cancer	0.00374	0.00533	CbGeAlD
Imatinib—CSF1R—lymphoid tissue—pharynx cancer	0.00367	0.00524	CbGeAlD
Imatinib—ABL2—lymph node—pharynx cancer	0.0034	0.00484	CbGeAlD
Imatinib—NQO2—head—pharynx cancer	0.00337	0.0048	CbGeAlD
Imatinib—PDGFRA—head—pharynx cancer	0.00336	0.00479	CbGeAlD
Imatinib—KIT—lymphoid tissue—pharynx cancer	0.00334	0.00475	CbGeAlD
Imatinib—ABL1—trachea—pharynx cancer	0.00333	0.00475	CbGeAlD
Imatinib—CSF1R—spinal cord—pharynx cancer	0.00333	0.00475	CbGeAlD
Imatinib—PDGFRB—lymphoid tissue—pharynx cancer	0.00326	0.00464	CbGeAlD
Imatinib—PIP4K2C—lymph node—pharynx cancer	0.00321	0.00458	CbGeAlD
Imatinib—CA12—head—pharynx cancer	0.0031	0.00442	CbGeAlD
Imatinib—CA2—parotid gland—pharynx cancer	0.00307	0.00438	CbGeAlD
Imatinib—CA3—lymph node—pharynx cancer	0.00307	0.00437	CbGeAlD
Imatinib—CA1—lymphoid tissue—pharynx cancer	0.00305	0.00435	CbGeAlD
Imatinib—SLC47A1—spinal cord—pharynx cancer	0.00304	0.00434	CbGeAlD
Imatinib—KIT—spinal cord—pharynx cancer	0.00302	0.00431	CbGeAlD
Imatinib—CSF1R—head—pharynx cancer	0.00296	0.00422	CbGeAlD
Imatinib—PDGFRB—spinal cord—pharynx cancer	0.00295	0.00421	CbGeAlD
Imatinib—CA2—saliva-secreting gland—pharynx cancer	0.00294	0.00419	CbGeAlD
Imatinib—ABL1—lymphoid tissue—pharynx cancer	0.0029	0.00414	CbGeAlD
Imatinib—CA2—brainstem—pharynx cancer	0.00288	0.00411	CbGeAlD
Imatinib—LCK—lymph node—pharynx cancer	0.00285	0.00407	CbGeAlD
Imatinib—ABCG2—parotid gland—pharynx cancer	0.00285	0.00406	CbGeAlD
Imatinib—ORM1—spinal cord—pharynx cancer	0.00277	0.00395	CbGeAlD
Imatinib—CA1—spinal cord—pharynx cancer	0.00277	0.00394	CbGeAlD
Imatinib—ABCG2—saliva-secreting gland—pharynx cancer	0.00273	0.00388	CbGeAlD
Imatinib—SLC47A1—head—pharynx cancer	0.0027	0.00385	CbGeAlD
Imatinib—KIT—head—pharynx cancer	0.00269	0.00383	CbGeAlD
Imatinib—ABL1—spinal cord—pharynx cancer	0.00263	0.00375	CbGeAlD
Imatinib—PDGFRB—head—pharynx cancer	0.00262	0.00374	CbGeAlD
Imatinib—CA2—epithelium—pharynx cancer	0.00257	0.00366	CbGeAlD
Imatinib—CA1—head—pharynx cancer	0.00246	0.0035	CbGeAlD
Imatinib—NQO2—lymph node—pharynx cancer	0.00236	0.00336	CbGeAlD
Imatinib—PDGFRA—lymph node—pharynx cancer	0.00235	0.00336	CbGeAlD
Imatinib—ABL1—head—pharynx cancer	0.00234	0.00333	CbGeAlD
Imatinib—CA2—trachea—pharynx cancer	0.00227	0.00324	CbGeAlD
Imatinib—SLC22A1—head—pharynx cancer	0.00226	0.00321	CbGeAlD
Imatinib—CSF1R—lymph node—pharynx cancer	0.00207	0.00295	CbGeAlD
Imatinib—PTGS1—epithelium—pharynx cancer	0.00198	0.00283	CbGeAlD
Imatinib—CA2—lymphoid tissue—pharynx cancer	0.00198	0.00282	CbGeAlD
Imatinib—SLC47A1—lymph node—pharynx cancer	0.00189	0.0027	CbGeAlD
Imatinib—KIT—lymph node—pharynx cancer	0.00188	0.00268	CbGeAlD
Imatinib—PDGFRB—lymph node—pharynx cancer	0.00184	0.00262	CbGeAlD
Imatinib—CYP2D6—brainstem—pharynx cancer	0.00183	0.00261	CbGeAlD
Imatinib—CA2—spinal cord—pharynx cancer	0.00179	0.00255	CbGeAlD
Imatinib—PTGS1—trachea—pharynx cancer	0.00175	0.0025	CbGeAlD
Imatinib—ORM1—lymph node—pharynx cancer	0.00172	0.00246	CbGeAlD
Imatinib—CA1—lymph node—pharynx cancer	0.00172	0.00245	CbGeAlD
Imatinib—ABCG2—spinal cord—pharynx cancer	0.00166	0.00237	CbGeAlD
Imatinib—ABL1—lymph node—pharynx cancer	0.00164	0.00234	CbGeAlD
Imatinib—CA2—head—pharynx cancer	0.00159	0.00227	CbGeAlD
Imatinib—ALB—lymph node—pharynx cancer	0.00151	0.00215	CbGeAlD
Imatinib—PTGS1—spinal cord—pharynx cancer	0.00138	0.00197	CbGeAlD
Imatinib—PTGS1—head—pharynx cancer	0.00123	0.00175	CbGeAlD
Imatinib—ABCB1—epithelium—pharynx cancer	0.00117	0.00167	CbGeAlD
Imatinib—CA2—lymph node—pharynx cancer	0.00112	0.00159	CbGeAlD
Imatinib—ABCB1—trachea—pharynx cancer	0.00104	0.00148	CbGeAlD
Imatinib—ABCG2—lymph node—pharynx cancer	0.00103	0.00147	CbGeAlD
Imatinib—CYP2D6—head—pharynx cancer	0.00101	0.00144	CbGeAlD
Imatinib—ABCB1—lymphoid tissue—pharynx cancer	0.000903	0.00129	CbGeAlD
Imatinib—PTGS1—lymph node—pharynx cancer	0.000862	0.00123	CbGeAlD
Imatinib—ABCB1—spinal cord—pharynx cancer	0.000819	0.00117	CbGeAlD
Imatinib—ABCB1—head—pharynx cancer	0.000728	0.00104	CbGeAlD
Imatinib—CA2—Metabolism—ADH1B—pharynx cancer	0.000689	0.00231	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways in Glioblastoma—EGFR—pharynx cancer	0.000681	0.00228	CbGpPWpGaD
Imatinib—KIT—PI3K/AKT activation—EGFR—pharynx cancer	0.000676	0.00226	CbGpPWpGaD
Imatinib—ABL1—DNA Damage Response (only ATM dependent)—CCND1—pharynx cancer	0.000674	0.00226	CbGpPWpGaD
Imatinib—KIT—GAB1 signalosome—EGFR—pharynx cancer	0.000671	0.00225	CbGpPWpGaD
Imatinib—CA9—Metabolism—ADH7—pharynx cancer	0.000662	0.00222	CbGpPWpGaD
Imatinib—CA1—Metabolism—ADH1B—pharynx cancer	0.00066	0.00221	CbGpPWpGaD
Imatinib—CA2—Metabolism—B4GALT5—pharynx cancer	0.000658	0.00221	CbGpPWpGaD
Imatinib—PDGFRB—Constitutive PI3K/AKT Signaling in Cancer—EGFR—pharynx cancer	0.000655	0.0022	CbGpPWpGaD
Imatinib—PDGFRA—PI-3K cascade—EGFR—pharynx cancer	0.000655	0.0022	CbGpPWpGaD
Imatinib—KIT—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.000655	0.0022	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.000652	0.00218	CbGpPWpGaD
Imatinib—ABL1—DNA Damage Response—TP53—pharynx cancer	0.000647	0.00217	CbGpPWpGaD
Imatinib—PDGFRA—PI3K/AKT activation—EGFR—pharynx cancer	0.00064	0.00214	CbGpPWpGaD
Imatinib—PDGFRA—GAB1 signalosome—EGFR—pharynx cancer	0.000635	0.00213	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.000635	0.00213	CbGpPWpGaD
Imatinib—CA1—Metabolism—B4GALT5—pharynx cancer	0.000631	0.00211	CbGpPWpGaD
Imatinib—ABL2—Axon guidance—EGFR—pharynx cancer	0.000626	0.0021	CbGpPWpGaD
Imatinib—ABL1—miRNA Regulation of DNA Damage Response—TP53—pharynx cancer	0.000625	0.00209	CbGpPWpGaD
Imatinib—PDGFRA—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.00062	0.00208	CbGpPWpGaD
Imatinib—NTRK1—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000614	0.00206	CbGpPWpGaD
Imatinib—PDGFRB—PI-3K cascade—EGFR—pharynx cancer	0.00059	0.00198	CbGpPWpGaD
Imatinib—CA9—Metabolism—ADH1B—pharynx cancer	0.000581	0.00195	CbGpPWpGaD
Imatinib—PDGFRB—PI3K/AKT activation—EGFR—pharynx cancer	0.000576	0.00193	CbGpPWpGaD
Imatinib—PDGFRB—GAB1 signalosome—EGFR—pharynx cancer	0.000572	0.00192	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.000572	0.00192	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.000571	0.00192	CbGpPWpGaD
Imatinib—PDGFRB—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.000559	0.00187	CbGpPWpGaD
Imatinib—CA9—Metabolism—B4GALT5—pharynx cancer	0.000555	0.00186	CbGpPWpGaD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000554	0.00186	CbGpPWpGaD
Imatinib—ABL1—Retinoblastoma (RB) in Cancer—TP53—pharynx cancer	0.000531	0.00178	CbGpPWpGaD
Imatinib—LCK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—pharynx cancer	0.000526	0.00176	CbGpPWpGaD
Imatinib—NTRK1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000522	0.00175	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.000519	0.00174	CbGpPWpGaD
Imatinib—KIT—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000518	0.00173	CbGpPWpGaD
Imatinib—NTRK1—MAPK Signaling Pathway—TP53—pharynx cancer	0.000515	0.00173	CbGpPWpGaD
Imatinib—ABCB1—lymph node—pharynx cancer	0.000509	0.000726	CbGeAlD
Imatinib—KIT—Disease—B4GALT5—pharynx cancer	0.000505	0.00169	CbGpPWpGaD
Imatinib—KIT—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000495	0.00166	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CD79A—pharynx cancer	0.000494	0.00166	CbGpPWpGaD
Imatinib—PDGFRA—Focal Adhesion—CCND1—pharynx cancer	0.000492	0.00165	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00049	0.00164	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00049	0.00164	CbGpPWpGaD
Imatinib—KIT—Signaling by ERBB4—EGFR—pharynx cancer	0.000487	0.00163	CbGpPWpGaD
Imatinib—PDGFRA—Disease—B4GALT5—pharynx cancer	0.000478	0.0016	CbGpPWpGaD
Imatinib—LCK—PI-3K cascade—EGFR—pharynx cancer	0.000474	0.00159	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000469	0.00157	CbGpPWpGaD
Imatinib—PDGFRA—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.000469	0.00157	CbGpPWpGaD
Imatinib—ABL1—Cell Cycle—TP53—pharynx cancer	0.000468	0.00157	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CD79A—pharynx cancer	0.000468	0.00157	CbGpPWpGaD
Imatinib—KIT—Downstream signal transduction—EGFR—pharynx cancer	0.000465	0.00156	CbGpPWpGaD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000465	0.00156	CbGpPWpGaD
Imatinib—KIT—Signaling by FGFR—EGFR—pharynx cancer	0.000463	0.00155	CbGpPWpGaD
Imatinib—LCK—PI3K/AKT activation—EGFR—pharynx cancer	0.000463	0.00155	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by ERBB4—EGFR—pharynx cancer	0.000461	0.00155	CbGpPWpGaD
Imatinib—KIT—Signaling by ERBB2—EGFR—pharynx cancer	0.000461	0.00154	CbGpPWpGaD
Imatinib—LCK—GAB1 signalosome—EGFR—pharynx cancer	0.000459	0.00154	CbGpPWpGaD
Imatinib—KIT—DAP12 signaling—EGFR—pharynx cancer	0.000459	0.00154	CbGpPWpGaD
Imatinib—KIT—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000452	0.00151	CbGpPWpGaD
Imatinib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.000448	0.0015	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—EGFR—pharynx cancer	0.000447	0.0015	CbGpPWpGaD
Imatinib—NTRK1—Circadian rythm related genes—TP53—pharynx cancer	0.000447	0.0015	CbGpPWpGaD
Imatinib—ABL1—DNA Damage Response (only ATM dependent)—TP53—pharynx cancer	0.000444	0.00149	CbGpPWpGaD
Imatinib—PDGFRB—Focal Adhesion—CCND1—pharynx cancer	0.000443	0.00148	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000441	0.00148	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signal transduction—EGFR—pharynx cancer	0.000441	0.00148	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by FGFR—EGFR—pharynx cancer	0.000438	0.00147	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by ERBB2—EGFR—pharynx cancer	0.000436	0.00146	CbGpPWpGaD
Imatinib—PDGFRA—DAP12 signaling—EGFR—pharynx cancer	0.000434	0.00145	CbGpPWpGaD
Imatinib—KIT—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000431	0.00145	CbGpPWpGaD
Imatinib—KIT—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000431	0.00145	CbGpPWpGaD
Imatinib—KIT—DAP12 interactions—EGFR—pharynx cancer	0.000431	0.00145	CbGpPWpGaD
Imatinib—PDGFRB—Disease—B4GALT5—pharynx cancer	0.000431	0.00144	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00043	0.00144	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000428	0.00143	CbGpPWpGaD
Imatinib—KIT—Signaling by EGFR—EGFR—pharynx cancer	0.000428	0.00143	CbGpPWpGaD
Imatinib—KIT—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000424	0.00142	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000422	0.00142	CbGpPWpGaD
Imatinib—PDGFRB—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.000422	0.00142	CbGpPWpGaD
Imatinib—KIT—Signaling by PDGF—EGFR—pharynx cancer	0.000422	0.00141	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CD79A—pharynx cancer	0.000421	0.00141	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB4—EGFR—pharynx cancer	0.000416	0.00139	CbGpPWpGaD
Imatinib—PDGFRA—DAP12 interactions—EGFR—pharynx cancer	0.000408	0.00137	CbGpPWpGaD
Imatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000408	0.00137	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000408	0.00137	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.000407	0.00136	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR—EGFR—pharynx cancer	0.000405	0.00136	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000401	0.00134	CbGpPWpGaD
Imatinib—NTRK1—Signaling by NGF—EGFR—pharynx cancer	0.000401	0.00134	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by PDGF—EGFR—pharynx cancer	0.000399	0.00134	CbGpPWpGaD
Imatinib—KIT—B Cell Activation—EGFR—pharynx cancer	0.000399	0.00134	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signal transduction—EGFR—pharynx cancer	0.000397	0.00133	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR—EGFR—pharynx cancer	0.000395	0.00132	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB2—EGFR—pharynx cancer	0.000393	0.00132	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 signaling—EGFR—pharynx cancer	0.000391	0.00131	CbGpPWpGaD
Imatinib—PDGFRA—Focal Adhesion—EGFR—pharynx cancer	0.000386	0.00129	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000385	0.00129	CbGpPWpGaD
Imatinib—ABL1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.000385	0.00129	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000384	0.00129	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000384	0.00129	CbGpPWpGaD
Imatinib—KIT—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000382	0.00128	CbGpPWpGaD
Imatinib—PDGFRA—B Cell Activation—EGFR—pharynx cancer	0.000378	0.00127	CbGpPWpGaD
Imatinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—pharynx cancer	0.000372	0.00125	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CNDP2—pharynx cancer	0.00037	0.00124	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 interactions—EGFR—pharynx cancer	0.000368	0.00123	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000368	0.00123	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000368	0.00123	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CNDP2—pharynx cancer	0.000367	0.00123	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CNDP2—pharynx cancer	0.000366	0.00123	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR—EGFR—pharynx cancer	0.000365	0.00122	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.000363	0.00122	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000363	0.00122	CbGpPWpGaD
Imatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000362	0.00121	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000361	0.00121	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by PDGF—EGFR—pharynx cancer	0.00036	0.00121	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CNDP2—pharynx cancer	0.000355	0.00119	CbGpPWpGaD
Imatinib—LCK—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000354	0.00119	CbGpPWpGaD
Imatinib—PDGFRB—Focal Adhesion—EGFR—pharynx cancer	0.000348	0.00116	CbGpPWpGaD
Imatinib—LCK—Disease—B4GALT5—pharynx cancer	0.000346	0.00116	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—TP53—pharynx cancer	0.000345	0.00116	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.000342	0.00115	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CNDP2—pharynx cancer	0.000341	0.00114	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—EGFR—pharynx cancer	0.00034	0.00114	CbGpPWpGaD
Imatinib—LCK—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000339	0.00114	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD79A—pharynx cancer	0.000338	0.00113	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000337	0.00113	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ADH7—pharynx cancer	0.000335	0.00112	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—EGFR—pharynx cancer	0.000334	0.00112	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ADH7—pharynx cancer	0.000332	0.00111	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ADH7—pharynx cancer	0.000331	0.00111	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—TP53—pharynx cancer	0.000326	0.00109	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000326	0.00109	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000323	0.00108	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—TP53—pharynx cancer	0.000322	0.00108	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ADH7—pharynx cancer	0.000321	0.00108	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—EGFR—pharynx cancer	0.000319	0.00107	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—EGFR—pharynx cancer	0.000317	0.00106	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—EGFR—pharynx cancer	0.000315	0.00106	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—EGFR—pharynx cancer	0.000314	0.00105	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000309	0.00104	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ADH7—pharynx cancer	0.000309	0.00103	CbGpPWpGaD
Imatinib—KIT—Immune System—CD79A—pharynx cancer	0.0003	0.001	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000295	0.000989	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000295	0.000989	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—EGFR—pharynx cancer	0.000295	0.000989	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—EGFR—pharynx cancer	0.000294	0.000985	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ADH1B—pharynx cancer	0.000293	0.000983	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—EGFR—pharynx cancer	0.000293	0.000981	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ADH1B—pharynx cancer	0.000291	0.000975	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ADH1B—pharynx cancer	0.00029	0.000973	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.00029	0.000972	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—EGFR—pharynx cancer	0.000289	0.000968	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD79A—pharynx cancer	0.000284	0.000951	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000283	0.000949	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ADH1B—pharynx cancer	0.000282	0.000945	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—B4GALT5—pharynx cancer	0.00028	0.00094	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—EGFR—pharynx cancer	0.000278	0.000932	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—B4GALT5—pharynx cancer	0.000278	0.000931	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—B4GALT5—pharynx cancer	0.000277	0.00093	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CDH1—pharynx cancer	0.000275	0.000922	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—EGFR—pharynx cancer	0.000273	0.000916	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ADH1B—pharynx cancer	0.000271	0.000907	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—B4GALT5—pharynx cancer	0.000269	0.000903	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.000265	0.000888	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000262	0.000876	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CDH1—pharynx cancer	0.000261	0.000873	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—B4GALT5—pharynx cancer	0.000259	0.000867	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD79A—pharynx cancer	0.000256	0.000856	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—EGFR—pharynx cancer	0.000251	0.00084	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD79A—pharynx cancer	0.000249	0.000835	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ADH7—pharynx cancer	0.00024	0.000803	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CDH1—pharynx cancer	0.000235	0.000787	CbGpPWpGaD
Imatinib—ALB—Metabolism—CNDP2—pharynx cancer	0.000228	0.000765	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—EGFR—pharynx cancer	0.000221	0.000741	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.00021	0.000704	CbGpPWpGaD
Imatinib—ALB—Metabolism—ADH7—pharynx cancer	0.000206	0.000692	CbGpPWpGaD
Imatinib—LCK—Immune System—CD79A—pharynx cancer	0.000205	0.000687	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000205	0.000687	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—EGFR—pharynx cancer	0.000201	0.000674	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000201	0.000673	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CNDP2—pharynx cancer	0.0002	0.00067	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000188	0.000632	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CDH1—pharynx cancer	0.000188	0.000631	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000187	0.000626	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000185	0.000622	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000185	0.000621	CbGpPWpGaD
Imatinib—ALB—Metabolism—ADH1B—pharynx cancer	0.000181	0.000607	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ADH7—pharynx cancer	0.000181	0.000606	CbGpPWpGaD
Imatinib—ALB—Metabolism—B4GALT5—pharynx cancer	0.000173	0.00058	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ADH7—pharynx cancer	0.00017	0.000571	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000169	0.000566	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—EGFR—pharynx cancer	0.000168	0.000562	CbGpPWpGaD
Imatinib—KIT—Immune System—CDH1—pharynx cancer	0.000167	0.000559	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000163	0.000545	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—EGFR—pharynx cancer	0.000161	0.000539	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.00016	0.000535	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—EGFR—pharynx cancer	0.000159	0.000532	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000159	0.000532	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CDH1—pharynx cancer	0.000158	0.00053	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—EGFR—pharynx cancer	0.000158	0.000529	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000155	0.00052	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—EGFR—pharynx cancer	0.000152	0.000511	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000152	0.000508	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000149	0.000501	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000148	0.000497	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000146	0.000488	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000144	0.000484	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—EGFR—pharynx cancer	0.000143	0.000479	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000143	0.000479	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CDH1—pharynx cancer	0.000142	0.000477	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000142	0.000475	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—EGFR—pharynx cancer	0.000139	0.000467	CbGpPWpGaD
Imatinib—ABL1—Immune System—CDH1—pharynx cancer	0.000139	0.000465	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—EGFR—pharynx cancer	0.000137	0.00046	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—pharynx cancer	0.00013	0.000435	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000127	0.000424	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000123	0.000413	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000122	0.000409	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000121	0.000406	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—EGFR—pharynx cancer	0.000115	0.000384	CbGpPWpGaD
Imatinib—LCK—Immune System—CDH1—pharynx cancer	0.000114	0.000383	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000111	0.000373	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—EGFR—pharynx cancer	0.00011	0.000369	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CCND1—pharynx cancer	0.00011	0.000368	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—pharynx cancer	0.000107	0.000359	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADH1B—pharynx cancer	9.77e-05	0.000327	CbGpPWpGaD
Imatinib—KIT—Immune System—EGFR—pharynx cancer	9.76e-05	0.000327	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—B4GALT5—pharynx cancer	9.34e-05	0.000313	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—EGFR—pharynx cancer	9.24e-05	0.00031	CbGpPWpGaD
Imatinib—KIT—Disease—EGFR—pharynx cancer	9.01e-05	0.000302	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—EGFR—pharynx cancer	8.62e-05	0.000289	CbGpPWpGaD
Imatinib—PDGFRA—Disease—EGFR—pharynx cancer	8.53e-05	0.000286	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—EGFR—pharynx cancer	8.33e-05	0.000279	CbGpPWpGaD
Imatinib—ABL1—Immune System—EGFR—pharynx cancer	8.11e-05	0.000272	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCND1—pharynx cancer	8.05e-05	0.00027	CbGpPWpGaD
Imatinib—PDGFRB—Disease—EGFR—pharynx cancer	7.69e-05	0.000258	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCND1—pharynx cancer	7.62e-05	0.000255	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—pharynx cancer	7.23e-05	0.000242	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCND1—pharynx cancer	6.86e-05	0.00023	CbGpPWpGaD
Imatinib—LCK—Immune System—EGFR—pharynx cancer	6.68e-05	0.000224	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—pharynx cancer	6.4e-05	0.000214	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EGFR—pharynx cancer	6.31e-05	0.000212	CbGpPWpGaD
Imatinib—LCK—Disease—EGFR—pharynx cancer	6.17e-05	0.000207	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EGFR—pharynx cancer	5.98e-05	0.0002	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCND1—pharynx cancer	5.51e-05	0.000185	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EGFR—pharynx cancer	5.38e-05	0.00018	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—pharynx cancer	5.3e-05	0.000178	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—pharynx cancer	5.02e-05	0.000168	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—pharynx cancer	4.52e-05	0.000151	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EGFR—pharynx cancer	4.32e-05	0.000145	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—pharynx cancer	3.63e-05	0.000122	CbGpPWpGaD
